At Unbiased Science Jess
Steier wrote, "The Hepatitis B birth dose decision wasn’t a good-faith effort to rebuild vaccine confidence by offering more flexibility. Multiple observers at that ACIP meeting described it as predetermined, ideological, and political. Malone tweeted a response to President Trump saying, “Mission Accomplished.” Which mission was that? Members didn’t even understand what they were voting on. No new safety data was presented — just the assertion that absence of a specific type of evidence equals evidence of absence."
CIDRAP reported that the CDC is giving a grant to study the Hep B vaccine in Guinea-Bissau (West Africa). "The new study was awarded without any competition from any other scientists, giving it “the appearance of blatant cronyism,” said Angela Rasmussen, PhD, a virologist and professor at the University of Saskatchewan."
CIDRAP continued, "In June, Kennedy
used a single study by the Bandim group
to justify canceling more than $1 billion in funding for childhood vaccinations in developing countries. The observational study found an increased risk of death in children who received a combined vaccine for diphtheria, tetanus and pertussis (DPT) that hasn’t been used in the United States in three decades...Multiple scientists have criticized the Bandim group’s methodology and conclusions...Rasmussen notes that it would not be ethical to provide a birth dose of the hepatitis B vaccine to some babies but not others, given that doctors know the immunization saves lives, both in the early newborn period and decades later. Exposing thousands of babies to “a significant risk” of hepatitis B “in a low-income country with limited health care resources” would be “wildly unethical and a disgraceful use of American taxpayer money,” Rasmussen said."